When global drug supply chain issues crop up, they are 40% less likely to result in a meaningful drug shortage in Canada compared with the U.S., according to findings in JAMA Network.
Why it matters: Shortages are occurring more often and can be incredibly disruptive to U.S. health care, as most recently demonstrated by the IV fluid shortage.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,